Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis.

Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev (1996) 6.12

The emergence of Lyme disease. J Clin Invest (2004) 5.24

Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48

Babesiosis. Clin Microbiol Rev (2000) 3.97

Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev (1999) 2.82

Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol (1999) 2.39

An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med (2002) 2.25

Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun (1998) 2.12

Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother (2008) 2.02

T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med (1995) 1.95

Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun (1999) 1.91

The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun (1999) 1.79

Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection. Infect Immun (2000) 1.75

Detection and species determination of malaria parasites by PCR: comparison with microscopy and with ParaSight-F and ICT malaria Pf tests in a clinical environment. J Clin Microbiol (1999) 1.71

Diverse Lyme disease spirochetes bind integrin alpha IIb beta 3 on human platelets. Infect Immun (1994) 1.71

Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect Immun (1995) 1.68

Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med (2006) 1.67

Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun (1994) 1.66

Lyme disease: a growing threat to urban populations. Proc Natl Acad Sci U S A (1994) 1.66

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother (2009) 1.60

Antibiotic treatment of animals infected with Borrelia burgdorferi. Clin Microbiol Rev (2009) 1.51

Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther (2014) 1.48

The role of infections in autoimmune disease. Clin Exp Immunol (2009) 1.47

Reactive arthritis or chronic infectious arthritis? Ann Rheum Dis (2002) 1.46

The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med (1994) 1.41

Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cells. Infect Immun (1998) 1.39

Evaluation of a new culture medium for Borrelia burgdorferi. J Clin Microbiol (2000) 1.31

Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis. Mol Immunol (2008) 1.30

Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect Immun (1998) 1.29

The laboratory diagnosis of Lyme borreliosis: Guidelines from the Canadian Public Health Laboratory Network. Can J Infect Dis Med Microbiol (2007) 1.25

PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev (1997) 1.23

Chronic brucellosis and persistence of Brucella melitensis DNA. J Clin Microbiol (2009) 1.21

Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis. Mol Immunol (2007) 1.20

Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. J Clin Microbiol (1994) 1.18

The Lyme vaccine: a cautionary tale. Epidemiol Infect (2006) 1.17

Importance of sample preparation for molecular diagnosis of lyme borreliosis from urine. J Clin Microbiol (2002) 1.16

An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J Clin Microbiol (1997) 1.15

Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis. Arthritis Rheum (2010) 1.11

Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun (1995) 1.11

Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect Immun (2000) 1.09

Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut. Wien Klin Wochenschr (2006) 1.07

Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks. Infect Immun (1997) 1.07

Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol (1998) 1.05

Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins. Infect Immun (2002) 1.05

Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J Clin Microbiol (2001) 1.04

Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis. Infect Immun (2005) 1.04

Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease. Infect Immun (2005) 1.04

Genetic stability of Borrelia burgdorferi recovered from chronically infected immunocompetent mice. Infect Immun (1994) 1.03

Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis. Clin Infect Dis (2011) 1.03

Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis. Arthritis Rheum (2009) 1.02

Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl. J Bacteriol (2000) 1.02

Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3. Infect Immun (2006) 1.01

Borrelia burgdorferi needs chemotaxis to establish infection in mammals and to accomplish its enzootic cycle. Infect Immun (2012) 1.00

A case revealing the natural history of untreated Lyme disease. Nat Rev Rheumatol (2010) 0.99

Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol (1994) 0.98

Lyme disease: the next decade. Infect Drug Resist (2011) 0.98

The amber theory of Lyme arthritis: initial description and clinical implications. Clin Rheumatol (2012) 0.97

Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther (2003) 0.97

Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J Virol (1998) 0.96

Lyme arthritis: current concepts and a change in paradigm. Clin Vaccine Immunol (2007) 0.94

Review of evidence for immune evasion and persistent infection in Lyme disease. Int J Gen Med (2013) 0.94

Investigation of infectious agents associated with arthritis by reverse transcription PCR of bacterial rRNA. Arthritis Res Ther (2002) 0.93

Role of osteopontin in murine Lyme arthritis and host defense against Borrelia burgdorferi. Infect Immun (2002) 0.92

Detection and molecular typing of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks and in different patient samples from southwest Germany. Eur J Epidemiol (2001) 0.91

Host-pathogen interactions in the immunopathogenesis of Lyme disease. J Clin Immunol (1997) 0.91

5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis. J Immunol (2011) 0.90

Strong IgG antibody responses to Borrelia burgdorferi glycolipids in patients with Lyme arthritis, a late manifestation of the infection. Clin Immunol (2009) 0.89

Laboratory diagnosis of Lyme disease: advances and challenges. Infect Dis Clin North Am (2015) 0.88

Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis. Infect Immun (1996) 0.86

Laboratory testing for Lyme disease: possibilities and practicalities. J Clin Microbiol (2002) 0.85

Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes. Infect Immun (2000) 0.85

Arbobacteria - Pathogens Transmittable by Arthropods. Transfus Med Hemother (2008) 0.85

Discovery and targeted proteomics on cutaneous biopsies infected by borrelia to investigate lyme disease. Mol Cell Proteomics (2015) 0.84

Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am (2015) 0.84

[Early diagnosis of Lyme arthritis]. Z Rheumatol (2005) 0.83

A role for T cells in the pathogenesis of treatment-resistant Lyme arthritis. Mol Med (1995) 0.83

Bb2Bb3 regulation of murine Lyme arthritis is distinct from Ncf1 and independent of the phagocyte nicotinamide adenine dinucleotide phosphate oxidase. Am J Pathol (2005) 0.83

Borrelia burgdorferi lipoprotein BmpA activates pro-inflammatory responses in human synovial cells through a protein moiety. Microbes Infect (2008) 0.83

Dynamics of connective-tissue localization during chronic Borrelia burgdorferi infection. Lab Invest (2013) 0.82

Nucleic Acid Amplification Based Diagnostic of Lyme (Neuro-)borreliosis - Lost in the Jungle of Methods, Targets, and Assays? Open Neurol J (2012) 0.81

Lyme disease in urban areas, Chicago. Emerg Infect Dis (2007) 0.81

Comparison of in vitro culture, immunohistochemical staining, and PCR for detection of Borrelia burgdorferi in tissue from experimentally infected animals. J Clin Microbiol (1995) 0.81

Two forms of reactive arthritis? Ann Rheum Dis (1999) 0.80

Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment. Arthritis Rheum (2008) 0.80

Differential spirochetal infectivities to vector ticks of mice chronically infected by the agent of Lyme disease. J Clin Microbiol (1995) 0.80

Intraarticular corticosteroids in refractory childhood Lyme arthritis. Rheumatol Int (2014) 0.79

The challenge of early synovitis: multiple pathways to a common clinical syndrome. Arthritis Res (1999) 0.78

Resolution of Lyme arthritis, acute or prolonged: a new look. Inflammation (2000) 0.78

Lyme disease and current aspects of immunization. Arthritis Res (2001) 0.77

Biased T-cell antigen receptor repertoire in Lyme arthritis. Infect Immun (1998) 0.77

Quantification of Borrelia burgdorferi Membrane Proteins in Human Serum: A New Concept for Detection of Bacterial Infection. Anal Chem (2015) 0.77

Absence of Mycobacterium tuberculosis DNA in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis (1994) 0.77

How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted? Ann Rheum Dis (2001) 0.76

Increased IgA rheumatoid factor and V(H)1 associated cross reactive idiotype expression in patients with Lyme arthritis and neuroborreliosis. Ann Rheum Dis (1999) 0.76

Fetal outcome in murine Lyme disease. Infect Immun (1995) 0.76

Antibiotic treatment of Lyme borreliosis: what is the evidence? Ann Rheum Dis (2005) 0.76

Serum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritis. Clin Vaccine Immunol (2007) 0.76

Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains? Bosn J Basic Med Sci (2015) 0.76

Arbobacteria - Pathogens Transmittable by Arthropods. Transfus Med Hemother (2009) 0.75

Role of adrenomedullin in Lyme disease. Infect Immun (2010) 0.75

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05

The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum (1977) 9.14

Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med (1977) 7.42

Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med (1998) 6.52

Western blotting in the serodiagnosis of Lyme disease. J Infect Dis (1993) 6.45

The early clinical manifestations of Lyme disease. Ann Intern Med (1983) 5.73

Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest (1986) 5.72

Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci U S A (1996) 5.34

Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic gram-negative bacilli. J Clin Microbiol (1998) 5.27

Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis (1995) 5.26

Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. Ann Intern Med (1979) 4.73

Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol (1991) 4.59

Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory. J Clin Microbiol (1994) 4.44

Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med (1980) 4.12

Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis (1988) 4.08

Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08

Antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis (1984) 4.07

Neurologic abnormalities of Lyme disease. Medicine (Baltimore) (1979) 3.98

Babesiosis. Clin Microbiol Rev (2000) 3.97

Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol (1993) 3.82

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68

A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med (1992) 3.65

The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology (1985) 3.55

Chronic neurologic manifestations of Lyme disease. N Engl J Med (1990) 3.54

Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol (1999) 3.41

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med (1996) 3.38

Elimination of contaminating DNA within polymerase chain reaction reagents: implications for a general approach to detection of uncultured pathogens. J Clin Microbiol (1993) 3.22

The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20

Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun (1993) 3.04

Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis (1988) 3.02

Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science (1986) 3.01

Antibiotic therapy in Lyme disease. Ann Intern Med (1980) 2.93

A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (1986) 2.91

Treatment of the early manifestations of Lyme disease. Ann Intern Med (1983) 2.89

Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA (1996) 2.88

Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure. Clin Infect Dis (1998) 2.88

Identification of coryneform bacterial isolates by ribosomal DNA sequence analysis. J Clin Microbiol (2000) 2.87

Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect Immun (1995) 2.86

Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun (1994) 2.81

DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71

Preventing false positives: quantitative evaluation of three protocols for inactivation of polymerase chain reaction amplification products. J Clin Microbiol (1993) 2.63

Detection of Borrelia burgdorferi DNA in museum specimens of Ixodes dammini ticks. Science (1990) 2.58

Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg (1992) 2.57

Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Infect Immun (1994) 2.57

Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol (1978) 2.53

Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis. Ann Intern Med (1993) 2.52

Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med (1983) 2.50

The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J Virol (1987) 2.49

Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. J Immunol (1992) 2.49

Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med (1997) 2.48

Molecular diagnostics of infectious diseases. Clin Chem (1997) 2.47

Diagnosing early Lyme disease. Am J Med (1985) 2.41

Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med (1997) 2.38

A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med (1996) 2.37

Handwashing practices for the prevention of nosocomial infections. Ann Intern Med (1975) 2.36

Ribosomal DNA sequencing as a tool for identification of bacterial pathogens. Curr Opin Microbiol (1999) 2.35

Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med (2001) 2.34

Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol (1995) 2.26

Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med (1985) 2.23

Dependence of polymerase chain reaction product inactivation protocols on amplicon length and sequence composition. J Clin Microbiol (1993) 2.22

Isolation of a new subspecies, Bartonella vinsonii subsp. arupensis, from a cattle rancher: identity with isolates found in conjunction with Borrelia burgdorferi and Babesia microti among naturally infected mice. J Clin Microbiol (1999) 2.22

Molecular diagnosis of herpes simplex virus infections in the central nervous system. J Clin Microbiol (1999) 2.21

Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21

Treatment of early Lyme disease. Am J Med (1992) 2.18

Detection of herpes simplex virus DNA in genital and dermal specimens by LightCycler PCR after extraction using the IsoQuick, MagNA Pure, and BioRobot 9604 methods. J Clin Microbiol (2001) 2.16

Clinical pathologic correlations of Lyme disease by stage. Ann N Y Acad Sci (1988) 2.16

Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J Infect Dis (1994) 2.09

Laboratory diagnosis of central nervous system infections with herpes simplex virus by PCR performed with cerebrospinal fluid specimens. J Clin Microbiol (1997) 2.08

Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR. J Clin Microbiol (1995) 2.08

Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet (1993) 2.05

Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann Intern Med (1985) 2.04

Genetic heterogeneity of Borrelia burgdorferi in the United States. J Infect Dis (1997) 2.04

Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol (1985) 2.03

Comparison of protein A gene sequencing with pulsed-field gel electrophoresis and epidemiologic data for molecular typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2000) 2.03

Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum (1999) 2.01

DNA sequence, organization and regulation of the qa gene cluster of Neurospora crassa. J Mol Biol (1989) 1.99

A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med (1996) 1.96

Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol (1999) 1.95

The polymerase chain reaction: clinical applications. Adv Clin Chem (1992) 1.91

A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin. Proc Natl Acad Sci U S A (1985) 1.89

High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol (1988) 1.86

Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens. Clin Infect Dis (1998) 1.83

Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA (1996) 1.82

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis (2000) 1.82

Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res (2000) 1.82

Persistent parasitemia after acute babesiosis. N Engl J Med (1998) 1.81

Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens. Diagn Microbiol Infect Dis (1994) 1.81

Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol (1999) 1.80

Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med (1979) 1.79

The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun (1999) 1.79

Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med (1979) 1.79

Prevalence of granulocytic Ehrlichia infection among white-tailed deer in Wisconsin. J Clin Microbiol (1997) 1.78

Alteration of hsp82 gene expression by the gypsy transposon and suppressor genes in Drosophila melanogaster. Genes Dev (1989) 1.73

Babesiosis in Washington State: a new species of Babesia? Ann Intern Med (1993) 1.71

The T-cell proliferative assay in the diagnosis of Lyme disease. Ann Intern Med (1991) 1.70